Free Trial
OTCMKTS:ACAN

AmeriCann (ACAN) Stock Price, News & Analysis

$0.04
0.00 (0.00%)
(As of 07/19/2024 ET)
Today's Range
$0.04
$0.04
50-Day Range
$0.03
$0.09
52-Week Range
$0.03
$0.42
Volume
N/A
Average Volume
16,142 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ACAN stock logo

About AmeriCann Stock (OTCMKTS:ACAN)

AmeriCann, Inc. designs, develops, leases, and operates cannabis cultivation, processing, and manufacturing facilities in the United States. The company engages in the product manufacturing and greenhouse cultivation facilities for licensed cannabis business. Its flagship project is the Massachusetts Cannabis Center that is developed on a 52-acre parcel of land located in Freetown, southeastern Massachusetts. The company also provides medical cannabis and adult-use cannabis. The company was formerly known as Nevada Health Scan, Inc. and changed its name to AmeriCann, Inc. in 2014. AmeriCann, Inc. was incorporated in 2010 and is headquartered in Denver, Colorado.

ACAN Stock Price History

ACAN Stock News Headlines

Is Apple out of “juice” at a $3.5T market cap?
In roughly 40 years, Apple went from a little-known garage startup… To a multi-trillion dollar global corporation trading at all-time highs of over $200 per share. Many “experts” believe the stock’s wildly overvalued… But Apple’s investment in artificial intelligence could trigger an AI-fueled frenzy. And there’s a little-know strategy traders can use to tap into the AI craze.
AmeriCann, Inc. (ACAN)
American Express CD Rates: March 2024
Americann Inc ACAN
Is Apple out of “juice” at a $3.5T market cap?
In roughly 40 years, Apple went from a little-known garage startup… To a multi-trillion dollar global corporation trading at all-time highs of over $200 per share. Many “experts” believe the stock’s wildly overvalued… But Apple’s investment in artificial intelligence could trigger an AI-fueled frenzy. And there’s a little-know strategy traders can use to tap into the AI craze.
Best American Airlines Credit Cards of February 2024
Acanthe Developpement SA ACAN
The average American debt by type, age, and state
See More Headlines
Receive ACAN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AmeriCann and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Real Estate Services
Sub-Industry
Cannabis
Current Symbol
OTCMKTS:ACAN
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Timothy Ryan Keogh (Age 44)
    CEO, President & Director
    Comp: $180k
  • Mr. Benjamin J. Barton (Age 59)
    Founder, Chief Financial & Accounting Officer and Director
    Comp: $180k
  • Dr. Rien Havens Ph.D.
    Extraction & Infused Product Advisor and Member of Advisory Board
  • Mr. Eric Forington
    Genetics & Breeding Advisor and Member of Advisory Board
  • Dr. D. Michael Anderson
    Medical Advisor & Member of Advisory Board
  • Mr. Nick Brait
    Licensing & Compliance Advisor and Member of Advisory Board

ACAN Stock Analysis - Frequently Asked Questions

How have ACAN shares performed this year?

AmeriCann's stock was trading at $0.0850 at the beginning of the year. Since then, ACAN stock has decreased by 50.6% and is now trading at $0.0420.
View the best growth stocks for 2024 here
.

How do I buy shares of AmeriCann?

Shares of ACAN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of AmeriCann own?

Based on aggregate information from My MarketBeat watchlists, some other companies that AmeriCann investors own include Fulcrum Therapeutics (FULC), KushCo (KSHB), MedMen Enterprises (MMNFF), Leafbuyer Technologies (LBUY) and Invitae (NVTA).

This page (OTCMKTS:ACAN) was last updated on 7/20/2024 by MarketBeat.com Staff

From Our Partners